ARTICLE | Emerging Company Profile

Integrated Diagnostics: Multiplexed detection

Integrated Diagnostics: Blood-based proteomic tests to detect early stage disease

October 4, 2010 7:00 AM UTC

Integrated Diagnostics Inc. is developing diagnostics that measure the levels of hundreds of proteins in blood simultaneously to detect early stage diseases. The company initially plans to translate its extensive academic partnerships into clinical tests for lung cancer and Alzheimer's disease, where current diagnostic procedures are inadequate, invasive or impractical.

Most blood diagnostics are antibody-based and detect a limited number of proteins, which in turn limits their predictive power...